Lupin: Lupin receives US FDA nod for Mirabegron tablets. The pharma company has received approval from the United States Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA), Mirabegron extended-release tablets, to market in the US. Mirabegron is a generic equivalent of Myrbetriq extended-release tablets of ...
View more: Lupin gets USFDA nod for generic HIV drug